Mesenchymal Stem Cells
REPROCELL offers a variety of ready-to-ship products to support research with Mesenchymal Stem Cells (MSCs)—also called Mesenchymal Stromal Cells or Medicinal Signaling Cells. These products include iPSC-derived MSC (iMSC) lines, media, and other culture reagents.
MSCs for clinical use are also available. See GMP MSC Services.
| Cat. No. | Product name | CloneID | Donor Race | Donor Sex | Donor Age | Donor Clinical Status | MSC Source | Phenol Red-free? |
|---|---|---|---|---|---|---|---|---|
| RCRP025 | Repro MSC3 | RPChMSC003 | Asian-Indian | Female | 20 | Healthy | Derived from iPSC Strain RPChiPSSK003.2 (Cat No RCRP011N) |
No |
| RCRP026 | Repro MSC4 | RPChMSC003 | Asian-Indian | Female | 20 | Healthy | Derived from iPSC Strain RPChiPSSK003.2 (Cat No RCRP011N) |
Yes |
| RCRP038 | Repro MSC10 | ReproMSC10 | Caucasian | Female | 22 | Healthy | Derived from iPSC Strain RPC-LLF-34-F3 | Yes |
| RCRP049 | Repro MSC12 | ReproMSC12 | Caucasian | Male | 23 | Healthy | Derived from iPSC Strain RPC-SKH-44-F19 | Yes |
|
ReproMSC16 hTERT SV40 |
ReproMSC16 |
Caucasian | Male | 23 | Healthy |
Derived from iMSC Strain ReproMSC12 (Cat No RCRP049) |
Yes | |
| RCRP057 | StemEdit iMSC B2M/CIITA DKO ReproMSC14 | ReproMSC14 | Caucasian | Female | 22 | Healthy | Derived from iPSC Strain StemEdit hiPSC B2M/CIITA DKO (Cat No RCRP052) | Yes |
| RCRP058 | StemEdit iMSC B2M/CIITA DKO hTERT SV40 ReproMSC18 | ReproMSC18 | Caucasian | Female | 22 | Healthy | Derived by immortalization of StemEdit iMSC B2M/CIITA DKO ReproMSC14 (Cat No RCRP057) | Yes |
| CC-BM-hMSC-1, CC-BM-hMSC-10 |
Human Bone Marrow MSCs | n/a | Varies | Varies | 18-28 | Healthy | Human bone marrow | Yes |
NOTE: These MSC cell lines are developed for research use only. They are NOT suitable for use in clinical projects.
Brand: StemRNA™ by Stemgent® (REPROCELL®)
REPROCELL’s Ready-to-use MSCs are ideal for differentiation projects.
RCRP025
Repro MSC3 are ready-to-use, research-grade Human iMSCs derived from StemRNA™ iPSCs.
RCRP026
Repro MSC4 are ready-to-use, research-grade Human iMSCs derived from StemRNA™ iPSCs, prepared with Phenol Red-free media and reagents.
RCRP038
Repro MSC10 are ready-to-use, research-grade Human iMSCs generated from one of our StemRNA™ Clinical Lines, RPC-LLF-34-F3. The parental iPSC line was established from fibroblasts using the StemRNA Reprogramming Technology.
RCRP049
Repro MSC12 are ready-to-use, research-grade Human iMSCs generated from one of our StemRNA™ Clinical Lines, RPC-SKH-44-F19. The parental iPSC line was established from fibroblasts using the StemRNA Reprogramming Technology.
RCRP056
ReproMSC16 are ready-to-use, research-grade Human iMSCs, constitutively immortalized with hTERT and SV40, generated from one of our StemRNA™ Clinical Lines, RPC-SKH-44-F19. The parental iPSC line was established from fibroblasts using the StemRNA Reprogramming Technology.
RCRP057
ReproMSC14 are ready-to-use, research-grade Human iMSCs generated from one of our StemRNA™ Clinical Lines, RPC-LLF-34-F3. The parental iPSC line was established from fibroblasts using the StemRNA Reprogramming Technology that was subsequently engineered with biallelic knockouts of B2M and CIIT, key regulators of HLA Class I and Class II antigen presentation.
RCRP058
ReproMSC18 are ready-to-use, research-grade Human iMSCs generated from one of our StemRNA™ Clinical Lines, RPC-LLF-34-F3, that were immortalized with hTERT and SV40. The parental iPSC line was established from fibroblasts using the StemRNA Reprogramming Technology that was subsequently engineered with biallelic knockouts of B2M and CIITA, key regulators of HLA Class I and Class II antigen presentation.
Brand: Cellcolabs®
CC-BM-hMSC-1, CC-BM-hMSC-10
Primary Human Bone Marrow MSCs, Research Grade